title: Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
authors.affiliation: Department of Gastroenterohepatology, Çamlıca Erdem Hospital, İstanbul, Turkey. drbyasar@yahoo.com.
authors.forename: Bülent
authors.initials: B
authors.lastname: Yaşar
authors.forename: Şirin
authors.initials: Ş
authors.lastname: Yaşar
authors.forename: Pembegül
authors.initials: P
authors.lastname: Güneş
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects; D001706:Biopsy; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000379:methods; D005145:Face / Q000473:pathology; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007279:Injections, Subcutaneous / Q000379:methods; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008544:Melanocytes / Q000187:drug effects*; D008875:Middle Aged; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004338:Drug Combinations; D016898:Interferon-alpha; D012254:Ribavirin